Eli Lilly cuts price of weight-loss drug Zepbound
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly (LLY) stock in focus as company boosts U.S. medicine production investment to $50B, creating 3,000 skilled jobs & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results